Compare iShares Core S&P 500 ETF (IVV) vs Eli Lilly And Co (LLY) Price & Performance

iShares Core S&P 500 ETFTrade

Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

iShares Core S&P 500 ETF vs Eli Lilly And Co — how do they compare? iShares Core S&P 500 ETF trades at $751.33, while Eli Lilly And Co trades at $1,174 (market cap $1.02T). The key difference: Eli Lilly And Co pays a 0.6% dividend while iShares Core S&P 500 ETF pays none. Which is the better fit depends on your goals.

	IVV	LLY
Sector	Broad Market / Factor	Health
52-Week High	$763.10	$1.24K
52-Week Low	$624.65	$625.65
Market Cap	—	$1.02T
Enterprise Value	—	$1.06T
Dividend Yield	—	0.6%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Core S&P 500 ETF

IVV, tracking the S&P 500, trades at $745.67, down 0.14% with a bearish technical signal from moving averages. The fund remains heavily weighted toward technology stocks, with recent news highlighting concentration risks and debates over valuation. A dividend of $2.00 is scheduled for June 2026, providing income amid market volatility.

Outlook is cautious due to technical weakness and high tech exposure, though long-term growth prospects from AI and earnings strength offer potential. Key risks include market concentration, valuation concerns, and macroeconomic shifts impacting broad index performance.

Eli Lilly And Co

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IVV

Invesco S&P 500 Equal Weight Consumer Discretionary ETF seen as a Hold, likely underperforming IVV again.Seeking Alpha · 2 days agoNeutral BlackRock's MAXJ ETF offers S&P 500 returns with downside protection but caps gains at 10.6%.24/7 Wall Street · 3 days agoNeutral SPY ETF charges higher fees than its cheaper sibling SPYM with identical S&P 500 exposure.24/7 Wall Street · 4 days agoBearish View details →

LLY

Over 180 companies develop 200+ PD-1/PD-L1 inhibitors, reshaping cancer treatment landscape.Delveinsight · 3 hours agoBullish Novo Nordisk sues Eli Lilly over misleading GLP-1 drug ads claiming superior weight-loss results.Proactive Investors · 9 hours agoBearish Novo Nordisk sues Eli Lilly over misleading ads on obesity and diabetes drug efficacy.CNBC · 12 hours agoBearish View details →

About iShares Core S&P 500 ETF

IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.